Suppr超能文献

SARS-CoV-2 刺突蛋白可导致心血管疾病,与病毒感染无关。

SARS-CoV-2 spike protein causes cardiovascular disease independent of viral infection.

机构信息

Drug Discovery Center, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, U.S.A.

出版信息

Clin Sci (Lond). 2022 Mar 31;136(6):431-434. doi: 10.1042/CS20220028.

Abstract

The SARS-CoV-2 virus that results in COVID-19 has been found to damage multiple organs beyond the lung. Interestingly, the SARS-CoV-2 spike (S) protein can be found circulating in the blood of COVID-19 patients. Experimental findings are demonstrating that the circulating S protein can bind to receptors resulting in inflammation and cell, tissue, and organ damage. Avolio et al. previously determined that the S protein acting through the cluster of differentiation 147 (CD147) receptor, and another unknown mechanism had detrimental effects on human cardiac pericytes (Clin Sci (Lond) (2021) 135 (24): 2667-2689. DOI: 10.1042/CS20210735). These findings support the notion that circulating SARS-CoV-2 S protein could contribute to cardiovascular disease independent of viral infection. Future studies are needed to determine the effect of the S protein on pericytes in other organs and evaluate the effectiveness of CD147 receptor-blocking therapies to decrease organ damage caused by the S protein.

摘要

导致 COVID-19 的 SARS-CoV-2 病毒已被发现会损害肺部以外的多个器官。有趣的是,SARS-CoV-2 的刺突(S)蛋白可以在 COVID-19 患者的血液中循环。实验结果表明,循环中的 S 蛋白可以与受体结合,导致炎症和细胞、组织和器官损伤。Avolio 等人先前确定,S 蛋白通过分化抗原 147(CD147)受体起作用,以及另一种未知机制对人类心脏周细胞有不良影响(Clin Sci (Lond) (2021) 135 (24): 2667-2689. DOI: 10.1042/CS20210735)。这些发现支持这样一种观点,即循环中的 SARS-CoV-2 S 蛋白可能会导致心血管疾病,而与病毒感染无关。未来的研究需要确定 S 蛋白对其他器官中周细胞的影响,并评估 CD147 受体阻断疗法的有效性,以减少 S 蛋白引起的器官损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c6/8965847/68185a57ea86/cs-136-cs20220028-g1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验